Prediction models for cardiovascular disease risk in the general population: systematic review
Objective To provide an overview of prediction models for risk of cardiovascular disease
(CVD) in the general population. Design Systematic review. Data sources Medline and …
(CVD) in the general population. Design Systematic review. Data sources Medline and …
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart …
P Greenland, JS Alpert, GA Beller, EJ Benjamin… - Journal of the American …, 2010 - jacc.org
The recommendations listed in this document are, whenever possible, evidence based. An
extensive evidence review was conducted for the period beginning March 2008 through …
extensive evidence review was conducted for the period beginning March 2008 through …
Cardiovascular disease risk prediction using automated machine learning: A prospective study of 423,604 UK Biobank participants
Background Identifying people at risk of cardiovascular diseases (CVD) is a cornerstone of
preventative cardiology. Risk prediction models currently recommended by clinical …
preventative cardiology. Risk prediction models currently recommended by clinical …
Priority actions for the non-communicable disease crisis
R Beaglehole, R Bonita, R Horton, C Adams, G Alleyne… - The lancet, 2011 - thelancet.com
Summary The UN High-Level Meeting on Non-Communicable Diseases (NCDs) in
September, 2011, is an unprecedented opportunity to create a sustained global movement …
September, 2011, is an unprecedented opportunity to create a sustained global movement …
Hypertension in developing countries
MM Ibrahim, A Damasceno - The Lancet, 2012 - thelancet.com
Data from different national and regional surveys show that hypertension is common in
developing countries, particularly in urban areas, and that rates of awareness, treatment …
developing countries, particularly in urban areas, and that rates of awareness, treatment …
Growing epidemic of coronary heart disease in low-and middle-income countries
Coronary heart disease (CHD) is the single largest cause of death in the developed
countries and is one of the leading causes of disease burden in developing countries. In …
countries and is one of the leading causes of disease burden in developing countries. In …
Protection against malaria at 1 year and immune correlates following PfSPZ vaccination
AS Ishizuka, KE Lyke, A DeZure, AA Berry, TL Richie… - Nature medicine, 2016 - nature.com
Abstract An attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) vaccine, PfSPZ
Vaccine, is highly protective against controlled human malaria infection (CHMI) 3 weeks …
Vaccine, is highly protective against controlled human malaria infection (CHMI) 3 weeks …
Live Attenuated Malaria Vaccine Designed to Protect Through Hepatic CD8+ T Cell Immunity
JE Epstein, K Tewari, KE Lyke, BKL Sim, PF Billingsley… - Science, 2011 - science.org
Our goal is to develop a vaccine that sustainably prevents Plasmodium falciparum (Pf)
malaria in≥ 80% of recipients. Pf sporozoites (PfSPZ) administered by mosquito bites are …
malaria in≥ 80% of recipients. Pf sporozoites (PfSPZ) administered by mosquito bites are …
Predicting the 30-year risk of cardiovascular disease: the framingham heart study
MJ Pencina, RB D'Agostino Sr, MG Larson… - Circulation, 2009 - Am Heart Assoc
Background—Present cardiovascular disease (CVD) risk prediction algorithms were
developed for a≤ 10-year follow up period. Clustering of risk factors at younger ages and …
developed for a≤ 10-year follow up period. Clustering of risk factors at younger ages and …
[HTML][HTML] Protection against Plasmodium falciparum malaria by PfSPZ Vaccine
JE Epstein, KM Paolino, TL Richie, M Sedegah… - JCI insight, 2017 - ncbi.nlm.nih.gov
BACKGROUND: A radiation-attenuated Plasmodium falciparum (Pf) sporozoite (SPZ)
malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf …
malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf …